EP 3426676 A1 20190116 - HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE
Title (en)
HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE
Title (de)
GB-POLYPEPTID DES HUMANEN CYTOMEGALOVIRUS
Title (fr)
POLYPEPTIDE GB DE CYTOMÉGALOVIRUS HUMAIN
Publication
Application
Priority
- US 201662307423 P 20160311
- IB 2017051401 W 20170309
Abstract (en)
[origin: WO2017153954A1] The present invention relates to a polypeptide that includes at least one mutation in the fusion loop 1 region and/or in the fusion loop 2 region and/or in the furin-like cleavage site of a human cytomegalovirus gB polypeptide. In one embodiment, the polypeptide undergoes a structural conformation change in response to pH change.
IPC 8 full level
C07K 14/005 (2006.01)
CPC (source: EP)
C07K 14/005 (2013.01); C12N 2710/16122 (2013.01); C12N 2710/16134 (2013.01); C12N 2710/16171 (2013.01)
Citation (search report)
See references of WO 2017153954A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017153954 A1 20170914; CA 3016867 A1 20170914; EP 3426676 A1 20190116
DOCDB simple family (application)
IB 2017051401 W 20170309; CA 3016867 A 20170309; EP 17713783 A 20170309